Noninitiation of adjuvant chemotherapy in women with localized breast cancer: The breast cancer quality of care study

Journal of Clinical Oncology

Volumn 30, Issue 31, 2012, Pages 3800-3809

  Neugut, Alfred I ^a,b   Hillyer, Grace Clarke ^b   Kushi, Lawrence H ^e   Lamerato, Lois ^f   Leoce, Nicole ^b   Nathanson, S David ^f   Ambrosone, Christine B ^c   Bovbjerg, Dana H ^g   Mandelblatt, Jeanne S ^h   Magai, Carol ^d   Tsai, Wei Yann ^a,b   Jacobson, Judith S ^a,b   Hershman, Dawn L ^a,b  

^a Columbia University ^*  (United States)

^b Roswell Park Cancer Institute ^*  (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d LONG ISLAND UNIVERSITY   (United States)

^e KAISER PERMANENTE   (United States)

^f HENRY FORD HEALTH SYSTEM   (United States)

^g UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^h GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER SURVIVAL; CLINICAL ASSESSMENT; CLINICAL DECISION MAKING; DEMOGRAPHY; DOCTOR PATIENT RELATION; FEMALE; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TUMOR VOLUME;

ADULT; AGED; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; QUALITY OF HEALTH CARE; TREATMENT OUTCOME; TREATMENT REFUSAL; YOUNG ADULT;

EID: 84869228570     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.43.8168     Document Type: Article

References (47)

1. Clarke M, Collins R, Darby S, et al: Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 366:2087-2106, 2005
2. Early Breast Cancer Trialists' Collaborative Group (EBCTCG): Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet 365:1687-1717, 2005
3. Hershman D, McBride R, Jacobson JS, et al: Racial disparities in treatment and survival among women with early-stage breast cancer. J Clin Oncol 23:6639-6646, 2005 (Pubitemid 46190258)
4. Lyman GH, Dale DC, Crawford J: Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: A nationwide study of community practices. J Clin Oncol 21:4524-4531, 2003 (Pubitemid 46594022)
5. Partridge AH, Wang PS, Winer EP, et al: Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol 21:602-606, 2003 (Pubitemid 46621892)
6. Bickell NA, McEvoy MD: Physicians' reasons for failing to deliver effective breast cancer care: A framework for underuse. Med Care 41:442-446, 2003
7. Hershman DL, Wang X, McBride R, et al: Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women. Breast Cancer Res Treat 99:313-321, 2006 (Pubitemid 44337924)
8. Hershman DL, Wang X, McBride R, et al: Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival. Int J Radiat Oncol Biol Phys 65:1353-1360, 2006 (Pubitemid 44425226)
9. Fedewa SA, Ward EM, Stewart AK, et al: Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African American and Hispanic populations: A national cohort study 2004-2006. J Clin Oncol 28:4135-4141, 2010
10. Silliman RA, Guadagnoli E, Weitberg AB, et al: Age as a predictor of diagnostic and initial treatment intensity in newly diagnosed breast cancer patients. J Gerontol 44:M46-M50, 1989
11. Hershman DL, Kushi LH, Shao T, et al: Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol 28:4120-4128, 2010
12. Elkin EB, Hurria A, Mitra N, et al: Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: Assessing outcome in a population-based, observational cohort. J Clin Oncol 24:2757-2764, 2006 (Pubitemid 46630573)
13. Giordano SH, Duan Z, Kuo YF, et al: Use and outcomes of adjuvant chemotherapy in older women with breast cancer. J Clin Oncol 24:2750-2756, 2006 (Pubitemid 46630572)
14. National Comprehensive Cancer Network, American Cancer Society: Breast cancer treatment guidelines for patients. Version VIII/September 2006. http://screening.iarc.fr/doc/Breast-VIII.pdf
15. Harlan LC, Clegg LX, Abrams J, et al: Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000. J Clin Oncol 24:872-877, 2006 (Pubitemid 46638838)
16. Wu XC, Lund MJ, Kimmick GG, et al: Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers. J Clin Oncol 30:142-150, 2012
17. Hershman DL, Buono D, McBride RB, et al: Influence of private practice setting and physician characteristics on the use of breast cancer adjuvant chemotherapy for elderly women. Cancer 115:3848-3857, 2009
18. Bhargava A, Du XL: Racial and socioeconomic disparities in adjuvant chemotherapy for older women with lymph node-positive, operable breast cancer. Cancer 115:2999-3008, 2009
19. Balasubramanian BA, Gandhi SK, Demissie K, et al: Use of adjuvant systemic therapy for early breast cancer among women 65 years of age and older. Cancer Control 14:63-68, 2007 (Pubitemid 46168966)
20. Neugut AI, Hillyer GC, Kushi LH, et al: The Breast Cancer Quality of Care Study (BQUAL): A multi-center study to determine causes for noncompliance with breast cancer adjuvant therapy. Breast J 18:203-213, 2012
21. National Comprehensive Cancer Network (NCCN): NCCN updates breast cancer guidelines 2008. http://www.nccn.org/about/news/newsinfo.asp?NewsID=127
22. Schootman M, Jeffe DB, West MM, et al: Self-report by elderly breast cancer patients was an acceptable alternative to Surveillance, Epidemiology, and End Results (SEER) abstract data. J Clin Epidemiol 58:1316-1319, 2005 (Pubitemid 41608549)
23. Liu Y, Diamant AL, Thind A, et al: Validity of self-reports of breast cancer treatment in low-income, medically underserved women with breast cancer. Breast Cancer Res Treat 119:745-751, 2010
24. Phillips KA, Milne RL, Buys S, et al: Agreement between self-reported breast cancer treatment and medical records in a population-based Breast Cancer Family Registry. J Clin Oncol 23:4679-4686, 2005 (Pubitemid 46224070)
25. Maunsell E, Drolet M, Ouhoummane N, et al: Breast cancer survivors accurately reported key treatment and prognostic characteristics. J Clin Epidemiol 58:364-369, 2005 (Pubitemid 40601984)
26. Charlson ME, Pompei P, Ales KL, et al: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40:373-383, 1987 (Pubitemid 17055592)
27. Llewellyn-Thomas HA, McGreal MJ, Thiel EC, et al: Patients' willingness to enter clinical trials: Measuring the association with perceived benefit and preference for decision participation. Soc Sci Med 32:35-42, 1991
28. Mandelblatt JS, Sheppard VB, Hurria A, et al: Breast cancer adjuvant chemotherapy decisions in older women: The role of patient preference and interactions with physicians. J Clin Oncol 28:3146-3153, 2010
29. Miller MD, Ferris DG: Measurement of subjective phenomena in primary care research: The Visual Analogue Scale. Fam Pract Res J 13:15-24, 1993
30. Sherbourne CD, Stewart AL: The MOS social support survey. Soc Sci Med 32:705-714, 1991
31. Scheier MF, Carver CS: Optimism, coping, and health: Assessment and implications of generalized outcome expectancies. Health Psychol 4:219-247, 1985
32. Watson M, Greer S, Young J, et al: Development of a questionnaire measure of adjustment to cancer: The MAC scale. Psychol Med 18:203-209, 1988 (Pubitemid 18071647)
33. Weiss DS, Marmar CR: The Impact of Event Scale-Revised, in Wilson JP, Keane TM (eds): Assessing Psychological Trauma and PTSD. New York, NY, Guilford Press, 1997, pp 399-411
34. Chew LD, Bradley KA, Boyko EJ: Brief questions to identify patients with inadequate health literacy. Fam Med 36:588-594, 2004 (Pubitemid 39209565)
35. Thompson HS, Valdimarsdottir HB, Winkel G, et al: The Group-Based Medical Mistrust Scale: Psychometric properties and association with breast cancer screening. Prev Med 38:209-218, 2004 (Pubitemid 38050292)
36. Stewart AL, Nápoles-Springer AM, Gregorich SE, et al: Interpersonal processes of care survey: Patient-reported measures for diverse groups. Health Serv Res 42:1235-1256, 2007 (Pubitemid 46699467)
37. Muss HB, Berry DA, Cirrincione C, et al: Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: The Cancer and Leukemia Group B experience. J Clin Oncol 25:3699-3704, 2007 (Pubitemid 47372610)
38. Neugut AI, Hillyer GC, Kushi LH, et al: Noninitiation of adjuvant hormonal therapy in women with hormone receptor-positive breast cancer: The Breast Cancer Quality of Care Study (BQUAL). Breast Cancer Res Treat 134:419-428, 2012
39. Hesketh PJ: Chemotherapy-induced nausea and vomiting. N Engl J Med 358:2482-2494, 2008
40. Duric VM, Stockler MR, Heritier S, et al: Patients' preferences for adjuvant chemotherapy in early breast cancer: What makes AC and CMF worthwhile now? Ann Oncol 16:1786-1794, 2005 (Pubitemid 41631241)
41. Duric VM, Butow PN, Sharpe L, et al: Psychosocial factors and patients' preferences for adjuvant chemotherapy in early breast cancer. Psychooncology 16:48-59, 2007 (Pubitemid 46189077)
42. Mosier KL, Fischer U: The role of affect in naturalistic decision making. J Cogn Eng Decis Making 4:240-255, 2010
43. Bickell NA, Weidmann J, Fei K, et al: Underuse of breast cancer adjuvant treatment: Patient knowledge, beliefs, and medical mistrust. J Clin Oncol 27:5160-5167, 2009
44. Fink AK, Gurwitz J, Rakowski W, et al: Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor-positive breast cancer. J Clin Oncol 22:3309-3315, 2004 (Pubitemid 41103687)
45. Kimmick G, Anderson R, Camacho F, et al: Adjuvant hormonal therapy use among insured, low-income women with breast cancer. J Clin Oncol 27:3445-3451, 2009
46. Magai C, Consedine NS, Adjei BA, et al: Psychosocial influences on suboptimal adjuvant breast cancer treatment adherence among African American women: Implications for education and intervention. Health Educ Behav 35:835-854, 2008
47. Bickell NA, LePar F, Wang JJ, et al: Lost opportunities: Physicians' reasons and disparities in breast cancer treatment. J Clin Oncol 25:2516-2521, 2007 (Pubitemid 47041223)